0001209191-23-036814.txt : 20230613
0001209191-23-036814.hdr.sgml : 20230613
20230613171311
ACCESSION NUMBER: 0001209191-23-036814
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230609
FILED AS OF DATE: 20230613
DATE AS OF CHANGE: 20230613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tuckson Reed Vaughn
CENTRAL INDEX KEY: 0001511051
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36579
FILM NUMBER: 231012119
MAIL ADDRESS:
STREET 1: C/O UNITEDHEALTH GROUP INCORPORATED
STREET 2: 9900 BREN ROAD EAST
CITY: MINNETONKA
STATE: MN
ZIP: 55123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001501756
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205258327
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: (650) 649-1004
MAIL ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc.
DATE OF NAME CHANGE: 20100921
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-09
0
0001501756
Adverum Biotechnologies, Inc.
ADVM
0001511051
Tuckson Reed Vaughn
C/O ADVERUM BIOTECHNOLOGIES, INC.
100 CARDINAL WAY
REDWOOD CITY
CA
94063
1
0
0
0
0
Stock Option (Right to Buy)
1.56
2023-06-09
4
A
0
40000
0.00
A
2033-06-08
Common Stock
40000
40000
D
The shares subject to the option will vest on the earlier of June 9, 2024 or the 2024 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.
Reed V. Tuckson, by /s/ Ron A. Metzger, Attorney-in-Fact
2023-06-13